Antenatal Presentation of MRPS22 ‐Related Mitochondrial Disease Confirmed With Rapid Proteomics
Authors:
- Megan BallMBMegan Ball
- MitoMDT Diagnostic Network for Genomics and OmicsMOMitoMDT Diagnostic Network for Genomics and Omics
- David R. ThorburnDTDavid R. Thorburn
- Alison G. ComptonACAlison G. Compton
Open Access
- 24 April 2026
- journal article
- Published by Wiley in JIMD Reports
- Vol. 67 (3) , e70092
Abstract
MRPS22 ‐related mitochondrial disease (MIM#611719) is a rare autosomal recessive disorder caused by defects in the mitochondrial ribosomal protein S22, a component of the small mitoribosomal subunit essential for mitochondrial translation. Of the few reported cases, most present antenatally with a severe phenotype, conveying a poor prognosis. We describe a fetus with severe antenatal‐onset MRPS22 ‐related mitochondrial disease and the use of multi‐omics in the molecular diagnosis. A primigravida underwent termination of pregnancy following identification of multiple congenital anomalies (hydrops fetalis, microcephaly, corpus callosal agenesis, periventricular cysts and cardiac hypertrophy) on ultrasound at 20 + 2 weeks' gestation, confirmed on fetal magnetic resonance imaging. Trio genome sequencing revealed compound heterozygous variants in MRPS22 (NM_020191.4: c.509G>A; p.(Arg170His) and c.565C>G; p.(Arg189Gly)). Rapid proteomic analysis demonstrated destabilisation of the small mitoribosomal subunit and combined reduction of OXPHOS complexes, supporting the pathogenicity of the variants. This case consolidates the antenatal phenotype of severe MRPS22‐related disease and highlights the importance of considering mitochondrial disease in the differential diagnosis of congenital anomalies, especially hydrops fetalis and corpus callosum anomalies. This study provides evidence for the utility of multi‐omic approaches (trio genome sequencing, proteomics) in confirming variant pathogenicity following pregnancy loss, enabling accurate diagnosis, and informing reproductive counselling for affected families.Keywords
Funding Information
- Mito Foundation (G067)
- Mito Foundation (G189)
- Mito Foundation (S021)
- Mito Foundation (S037)
- Royal Children's Hospital Foundation
This publication has 44 references indexed in Scilit:
- The structure of the human mitochondrial ribosomeScience, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- MRPS22 mutation causes fatal neonatal lactic acidosis with brain and heart abnormalitiesneurogenetics, 2015
- COQ4 Mutations Cause a Broad Spectrum of Mitochondrial Disorders Associated with CoQ10 DeficiencyThe American Journal of Human Genetics, 2015
- The effect of small molecules on nuclear-encoded translation diseasesBiochimie, 2014
- Antenatal manifestations of mitochondrial disordersJournal of Inherited Metabolic Disease, 2013
- Mutation in mitochondrial ribosomal protein MRPS22 leads to Cornelia de Lange-like phenotype, brain abnormalities and hypertrophic cardiomyopathyEuropean Journal of Human Genetics, 2010
- The effect of mutated mitochondrial ribosomal proteins S16 and S22 on the assembly of the small and large ribosomal subunits in human mitochondriaMitochondrion, 2008
- Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutationJournal of Medical Genetics, 2007
- Antenatal manifestations of mitochondrial respiratory chain deficiencyThe Journal of Pediatrics, 2003